Study on qi deficiency syndrome identification modes of coronary heart disease based on metabolomic biomarkers

Area of Science:

• Systems biology
• Metabolomics
• Biomarker discovery

Background:

• Coronary heart disease (CHD) is a leading cause of mortality.
• Systems biology approaches are increasingly vital in biological research.
• Metabolomics quantifies metabolites and their dynamic responses in living systems.

Purpose of the Study:

• To characterize plasma metabolites in CHD patients.
• To identify metabolic differences in CHD patients with Qi deficiency syndrome.
• To explore metabolic biomarkers and understand pathogenesis in CHD and its subtypes.

Main Methods:

• Plasma metabolomic profiling of CHD patients and healthy controls.
• Statistical analysis to identify characteristic metabolites and significant differences.
• Comparative analysis between CHD patients with and without Qi deficiency syndrome.

Main Results:

• Identified 25 characteristic plasma metabolites differentiating CHD patients from healthy individuals.
• Discovered 4 significant metabolic variables distinguishing Qi deficiency from non-Qi deficiency in CHD patients.
• Provided a basis for understanding metabolic rules and pathogenesis in CHD Qi deficiency syndrome.

Conclusions:

• Plasma metabolomics can identify biomarkers for CHD.
• Metabolic profiling reveals distinct patterns in CHD Qi deficiency syndrome.
• This research advances the understanding of CHD pathogenesis through a metabolomic lens.